Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)

33.22 +1.18 (+3.68%) At close: 03:04PM CST

Sichuan Kelun Pharmaceutical Co., Ltd.

No.36 West Baihua Road
Qingyang District
Chengdu 610071
China
86 28 8612 7705
https://www.kelun.com

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full-time employees: 19,798

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Sichuan Liu	GM & Director	N/A	N/A	1984
Mr. Degui Lai	CFO & Deputy GM	N/A	N/A	1971
Mr. Hao Feng	Deputy GM & Secretary of the Board of Directors	N/A	N/A	1980
Mr. Nanchao Ding	Deputy General Manager	N/A	N/A	N/A
Mr. Wendi Fan	Deputy General Manager	N/A	N/A	1982
Ms. Yihong Liao	Deputy General Manager	N/A	N/A	1979
Ms. Liang Wang	Deputy General Manager	N/A	N/A	1973
Mr. Deguang Chen	Officer	N/A	N/A	1971

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.

Corporate governance

Sichuan Kelun Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of 1 June 2024 is 5. The pillar scores are Audit: 7; Board: 10; Shareholder rights: 2; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.